Cannapharmarx Inc (CPMD)
0.01
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Cannapharmarx Total Assets (Quarterly): 5.156M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 5.156M |
June 30, 2023 | 5.323M |
March 31, 2023 | 5.271M |
December 31, 2022 | 5.414M |
September 30, 2022 | 5.420M |
June 30, 2022 | 5.763M |
March 31, 2022 | 5.914M |
December 31, 2021 | 0.1143M |
September 30, 2021 | 7.039M |
June 30, 2021 | 8.849M |
March 31, 2021 | 8.786M |
December 31, 2020 | 8.748M |
September 30, 2020 | 16.45M |
June 30, 2020 | 16.04M |
March 31, 2020 | 13.32M |
December 31, 2019 | 16.02M |
September 30, 2019 | 22.47M |
June 30, 2019 | 21.01M |
March 31, 2019 | 21.04M |
December 31, 2018 | 10.10M |
September 30, 2018 | 0.7588M |
June 30, 2018 | 0.0222M |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
Date | Value |
---|---|
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.0017M |
September 30, 2016 | 0.0042M |
June 30, 2016 | 0.0075M |
March 31, 2016 | 0.0206M |
December 31, 2015 | 0.0121M |
September 30, 2015 | 0.3232M |
June 30, 2015 | 1.093M |
March 31, 2015 | 1.597M |
December 31, 2014 | 1.797M |
September 30, 2014 | 2.452M |
June 30, 2014 | 1.979M |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.1143M
Minimum
Dec 2021
22.47M
Maximum
Sep 2019
9.839M
Average
7.893M
Median
Total Assets (Quarterly) Benchmarks
Acasti Pharma Inc | 76.18M |
Aurinia Pharmaceuticals Inc | 548.06M |
Edesa Biotech Inc | 6.475M |
Lexaria Bioscience Corp | 6.352M |
Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 25.79M |
Shareholders Equity (Quarterly) | -20.63M |